ANF-Rho: A Dose-Ranging Phase I Study to Determine Safety, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers

被引：0

作者：

Parmar, Deven V. ^{[1
]}

Byczkowski, Daniel ^{[1
]}

Jubin, Ronald G. ^{[1
]}

Abuchowski, Abraham ^{[1
]}

Buontempo, Peter ^{[1
]}

Gitlin, Gerry ^{[1
]}

Boro, Michelle ^{[1
]}

Misra, Hemant K. ^{[1
]}

机构：

[1] Prolong Pharmaceut, South Plainfield, NJ USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] Pharmacokinetics, pharmacodynamics, and safety of frunexian in healthy Chinese volunteer adults: A randomized dose-escalation phase I study [J].

Zhang, Jia-yu ;

Ruan, Zou-rong ;

Jiang, Bo ;

Yang, Dan-dan ;

Wang, Jia-ying ;

Hu, Yin ;

Wang, Yong-rui ;

Wang, Yan-mei ;

Lin, Yun-fei ;

Wang, Ling-ling ;

Lou, Hong-gang .

CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (04)

[22] Phase I repeat-dose clinical study of safety, pharmacokinetics and pharmacodynamics of resveratrol [J].

Brown, Victoria ;

Patel, Ketan ;

Booth, Tristan ;

Crowell, James ;

Perloff, Marjorie ;

Tuck, Missy ;

Deyampert, Andrace ;

Brown, Karen ;

Gescher, Andreas ;

Steward, William ;

Brenner, Dean .

CANCER RESEARCH, 2008, 68 (09)

[23] Phase 1 Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers [J].

Merica, VarshaIyer Elizabeth ;

Ronseaux, Sebastien ;

Gamache, Tressa ;

Mulrow, Nancy J. ;

Belcijan, Anja ;

Callaghan, Michael U. .

BLOOD, 2021, 138

[24] A PHASE-I DOSE-RANGING SAFETY AND PHARMACOKINETICS STUDY OF A NOVEL ORAL THROMBOXANE SYNTHASE INHIBITOR, FCE-22, 178 [J].

LI, RC ;

NARANG, PK ;

LEWIS, RC ;

HATFIELD, NZ ;

ROSSI, DT ;

COLBORN, DC .

JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 33 (04) :373-380

[25] A Single Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Pegylated Interferon-Beta in Healthy Volunteers [J].

Grabstein, Kenneth ;

Wang, Aijun ;

Nairn, Natalie Winblade ;

Burge, Daniel J. .

ANNALS OF NEUROLOGY, 2011, 70 :S71-S72

[26] Pharmacokinetics of panomifene in healthy volunteers at phase I/a study [J].

ErdelyiToth, V ;

Gyergyay, F ;

Szamel, I ;

Pap, E ;

Kralovanszky, J ;

Bojti, E ;

Csorgo, M ;

Drabant, S ;

Klebovich, I .

ANTI-CANCER DRUGS, 1997, 8 (06) :603-609

[27] Safety, tolerability, pharmacokinetics and pharmacodynamics of losmapimod following a single intravenous or oral dose in healthy volunteers [J].

Barbour, April M. ;

Sarov-Blat, Lea ;

Cai, Gengqian ;

Fossler, Michael J. ;

Sprecher, Dennis L. ;

Graggaber, Johann ;

McGeoch, Adam T. ;

Maison, Jo ;

Cheriyan, Joseph .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (01) :99-106

[28] Pharmacodynamics and pharmacokinetics of dose ranging effects of Oralin versus s.c. regular insulin in healthy volunteers [J].

Cernea, S ;

Wohlgelernter, J ;

Kidron, M ;

Modi, P ;

Raz, I .

DIABETOLOGIA, 2004, 47 :A5-A5

[29] Pharmacodynamics and pharmacokinetics of dose ranging effects of oralin versus s.c. regular insulin in healthy volunteers [J].

Raz, I ;

Cernea, S ;

Wohlgelernter, J ;

Modi, P ;

Kidron, M .

DIABETES, 2004, 53 :A4-A4

[30] Phase I clinical trial evaluating the safety, tolerance, pharmacokinetics and pharmacodynamics of HSK21542 injection in healthy volunteers [J].

Shao, Rong ;

Wang, Hai-ying ;

Ruan, Zou-rong ;

Jiang, Bo ;

Yang, Dan-dan ;

Hu, Yin ;

Xu, Yi-chao ;

Yang, Jin-ting ;

Gao, Wei ;

Zhao, Wan-yun ;

Yan, Min ;

Lou, Honggang .

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 (06) :743-754

← 1 2 3 4 5 →